RHOA and endothelial dysfunction: Our results demonstrated that the S1PR2 antagonist (JTE-013) almost completely blocked endothelial dysfunction and associated fission and dysfunction of mitochondria under HG conditions along with down-regulated HG-promoted expression of RhoA/ROCK1.